Literature DB >> 23958935

The role of MDSCs in hepatocellular carcinoma--in vivo veritas?

Jörg Schrader1.   

Abstract

Entities:  

Keywords:  HCC; MDSC; hepatocellular carcinoma; myeloid derived suppressor cell

Mesh：

Year:  2013        PMID： 23958935     DOI： 10.1016/j.jhep.2013.08.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

Review 1.  High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cancer Immunol Immunother       Date:  2016-02-24       Impact factor: 6.968

2.  Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.

Authors:  Shuai Chen; Jianghong Cheng; Yanhong Zhong; Ruimin Liu; Zhongxian Lu; Xianyang Luo
Journal:  Oncogene       Date:  2022-04-11       Impact factor: 9.867

Review 3.  MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target.

Authors:  Chi Ma; Qianfei Zhang; Tim F Greten
Journal:  Cell Immunol       Date:  2021-01-21       Impact factor: 4.868

Review 4.  The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Alessandra Mangia; Salvatore Gruttadauria; Adriana Toro; Isidoro Di Carlo; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Michele Malaguarnera
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

5.  Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma.

Authors:  Stéphanie Lacotte; Florence Slits; Lorenzo A Orci; Jeremy Meyer; Graziano Oldani; Vaihere Delaune; Carmen Gonelle-Gispert; Philippe Morel; Christian Toso
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

Review 6.  Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.

Authors:  Qi Zhang; Yu Lou; Xue-Li Bai; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

Review 7.  Adaptive immunity in the liver.

Authors:  Zongwen Shuai; Miranda Wy Leung; Xiaosong He; Weici Zhang; Guoxiang Yang; Patrick Sc Leung; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

Review 8.  Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Kumar Jayant; Nagy Habib; Kai W Huang; Jane Warwick; Ramesh Arasaradnam
Journal:  Diagnostics (Basel)       Date:  2020-05-25

9.  Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.

Authors:  Yue Zhao; Timothy Wai Ho Shuen; Tan Boon Toh; Xue Ying Chan; Min Liu; Sue Yee Tan; Yong Fan; Hechuan Yang; Shridhar Ganpathi Lyer; Glenn Kunnath Bonney; Eva Loh; Kenneth Tou En Chang; Thiam Chye Tan; Weiwei Zhai; Jerry Kok Yen Chan; Edward Kai-Hua Chow; Cheng Ean Chee; Guan Huei Lee; Yock Young Dan; Pierce Kah-Hoe Chow; Han Chong Toh; Seng Gee Lim; Qingfeng Chen
Journal:  Gut       Date:  2018-03-30       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.